Recent studies have linked increased polycyclic aromatic hydrocarbons (PAHs) in air and adverse fetal health outcomes. Urinary PAH metabolites are of interest for exposure assessment if they can predict PAHs in air. We investigated exposure to PAHs by collecting air and urine samples among pregnant women pre-selected as living in ''high'' (downtown and close to steel mills, n ¼ 9) and ''low'' (suburban, n ¼ 10) exposure areas. We analyzed firstmorning urine voids from all 3 trimesters of pregnancy for urinary PAH metabolites and compared these to personal air PAH/PM 2.5 /NO 2 /NO X samples collected in the 3rd trimester. We also evaluated activities and home characteristics, geographic indicators and outdoor central site PM 2.5 /NO 2 / NO X (all trimesters). Personal air exposures to the lighter molecular weight (MW) PAHs were linked to indoor sources (candles and incense), whereas the heavier PAHs were related to outdoor sources. Geometric means of all personal air measurements were higher in the ''high'' exposure group. We suggest that centrally monitored heavier MW PAHs could be used to predict personal exposures for heavier PAHs only. Urine metabolites were only directly correlated with their parent air PAHs for phenanthrene (Pearson's r ¼ 0.31-0.45) and fluorene (r ¼ 0.37-0.58). Predictive models suggest that specific metabolites (3-hydroyxyfluorene and 3-hydroxyphenanthrene) may be related to their parent air PAH exposures. The metabolite 2-hydroxynaphthalene was linked to smoking and the metabolite 1-hydroxypyrene was linked to dietary exposures. For researchers interested in predicting exposure to airborne lighter MW PAHs using urinary PAH metabolites, we propose that hydroxyfluorene and hydroxyphenanthrene metabolites be considered.
Introduction
Polycyclic aromatic hydrocarbons (PAHs) are a group of organic compounds that form as a result of incomplete combustion, and the International Agency for Research on Cancer considers several PAHs as either known, probable or possible carcinogens. Individuals in urban areas are exposed to PAHs in air from sources, which include: motor vehicle emissions, asphalt paving, incense burning in the home (Tonne et al., 2004) , fireplaces and barbeques, proximity to industrial sources (e.g. steel mills) (Mucha et al., 2006) and tobacco smoke exposure (Aquilina et al., 2010) . In addition to inhalation exposure, biological dose of PAHs is influenced by dietary intakes from specific cooking methods such as grilling, barbequing or broiling (Viau et al., 2002) .
Recent epidemiological studies have demonstrated relationships between prenatal exposure to PAHs in air and adverse health outcomes, including intrauterine growth restriction (Choi et al., 2008a) . More broadly, studies from around the world have shown adverse impacts of maternal exposure to air pollution (PM 2.5 , NO 2 /NO X and PAHs) on fetal health outcomes (Bosetti et al., 2010) . Others have postulated that increased ambient PAH concentrations may be linked with increased DNA-level damage noted in maternal blood and infant cord blood (Perera et al., 2005) .
Although the carcinogenic contribution from low molecular weight (MW) PAHs are relatively lower than high MW PAHs as determined by the Toxicity Equivalence Approach (Rajput et al., 2010) , the low MW PAHs have been less studied. The inclusion in the environmental and health assessment process of the low MW PAHs and the general classification of PAHs as ''toxic'' by CEPA, as well as in comparable US EPA assessment and regulation of PAHs (CEPA, 1994; ATSDR, 1995) , makes it important to include both light and heavy MW species in exposure-health effects studies. The low MW PAHs contribute a substantial proportion to the exposure as indicated by the biomonitoring data. Published data on levels of urinary PAHs in pregnant women are limited, with data only available on 1-hydroxypyrene (1-PYR) (Llop et al., 2008; Suzuki et al., 2010) . One study has examined urinary 1-PYR levels in pregnancy and only found a statistically significant negative correlation with birth weight, birth length and head circumstances when both smokers and non-smokers were included in multiple regression analysis (Suzuki et al., 2010) . Given the increased susceptibility of the fetus, research on these lower MW PAHs are lacking. Our study is one of the first to measure a suite of both high and low MW PAHs in the urine of pregnant women.
We conducted this study in Hamilton, a Canadian city with an industrial area (mostly steel fabrication) located within the downtown core (see Figure 1 ). An earlier study in Hamilton (Sahsuvaroglu et al., 2006) found proximity to industrial land-use predicted higher concentrations of NO 2 (a commonly used marker of air pollution).
Although personal air sampling for PAHs would most directly approximate inhaled PAHs, it is also possible to analyze urine samples for PAH biomarkers. Biological monitoring is an appealing sampling method not only because of its relative simplicity compared to personal air sampling, but also because of its ability to measure total internal dose of a pollutant. The most commonly used urinary biomarker for exposure to PAHs, 1-PYR, has been shown to reflect elevated exposure in occupational cohorts (Hansen et al., 2008) and in some environmental studies (Castan˜o-Vinyals et al., 2004; Mucha et al., 2006; Li et al., 2008) . Generally, environmental exposure to ambient air PAHs is low compared to exposure to PAHs through diet, tobacco smoke or occupation. The half-life of 1-PYR in humans ranges from 6 to 35 h (after inhalation) and 4 to 12 h (after ingestion) (Jongeneelen et al., 1990; Buckley and Lioy, 1992; Brzeznicki et al., 1997; Aquilina et al., 2010) .
Recently, others reported reference ranges for 22 urinary PAH metabolites and determined that 1-PYR was useful as a single surrogate of PAH exposure (based on correlations between 1-PYR and other metabolites from 0.17 to 0.63) (Li et al., 2008) . Only a few studies to date have attempted to relate measurements of the more detailed suite of urinary PAH biomarkers to air exposure measurements (Castan˜o-Vinyals et al., 2004; Aquilina et al., 2010; Leroyer et al., 2010) in non-occupationally exposed cohorts and have found no associations between air PAHs and urinary metabolites of the same compounds. However, one recent study collected daily urine and air samples from eight volunteers over 8 days and found correlations with 24-h air exposure and excreted hydroxynaphthalene and hydroxyfluorene metabolites in urine (Li et al., 2010) . To date, no studies have measured air samples and urinary metabolites of PAHs in a cohort of pregnant women with repeat measurements of urinary metabolites across trimesters.
The primary objectives of this study were to: (1) investigate the relationships between personal-indoor-centrally monitored PAHs and other air pollutants; (2) investigate the relationships between urinary metabolites of PAHs and air samples of PAHs, specifically in pregnant women; and (3) investigate other personal, geographic and time-activity determinates of the urinary PAH metabolites. 
Methods

Study Design
This study investigated relationships between various metrics used to represent PAH air exposure among pregnant women. To maximize the power of the study given the small sample size, we targeted 10 women living in a predicted ''high'' ambient air pollution area and 10 in a ''low'' pollution area (determined by previous modeling; Sahsuvaroglu et al., 2006) . The groups were, in essence, ''living downtown'' vs the suburbs and/or up on the escarpment (see Figure 1) . Hamilton is bisected by the Niagara escarpment, which is a geographic feature that climbs from 60 to 200 m (approx.) in a short distance.
Study participants were recruited during their 1st trimester (before 13 weeks) through family physicians' offices, from Hamilton, ON, Canada (population approx. 500,000). Participants who met the selection criteria (non-smokers, living in Hamilton, not allergic to latex and fluent in English) and who agreed to be part of the study then provided informed consent. This research study was approved by the research ethics committees at Health Canada and McMaster University.
The study participants completed a detailed questionnaire (socio-economic status, home characteristics, food consumption, personal activities, smoking exposures, pregnancy complications and other environmental exposures) during the 3rd trimester visit to gather data on potential predictors of PAH concentrations. We geocoded participants' addresses (in ArcGIS) and calculated the distance to the nearest highway and the number of industrial land-use areas within 1 km and 200 m buffers of the home (DMTI Streets 2006 data used for street network and land-use parcels). Participants also completed a detailed food diary before each 24-h urine sample and we estimated the total PAHs mg/kg in food consumed.
Urine Samples
We collected first-morning voids (minimum 10 ml) once in each of the 1st, 2nd and 3rd trimesters of pregnancy. Samples were frozen until the session was completed and were shipped (weekly) to the National Center for Environmental Health laboratory at the Centers for Disease Control and Prevention in Atlanta, GA, USA for analysis. Results were obtained for 20 hydroxy-PAH (OH-PAHs) metabolites using enzymatic deconjugation of the analytes to yield free OH-PAHs, followed by automated liquid-liquid extraction and quantified by gas chromatography/isotope dilution high-resolution mass spectrometry (Li et al., 2006) . All concentration data were blank corrected based on the concentration of the contamination in blank samples in the same run. Two quality control samples and two blanks were run per 16 samples. Creatinine was determined using an enzymatic method and PAH metabolite concentrations were then creatinine normalized (Viau et al., 2004) .
Air Samples
For ease of scheduling, all participants were sampled during one of three 1-week sessions in early September (average daily temperature 25 1C), mid-November and early December 2007 (average daily temperature 2 1C). Beginning 2 days before the 3rd trimester urine sample (last morning of the air sampling), we conducted personal, indoor (in the home) and outdoor (central site) air monitoring for PAHs (URG pesticide sampler, Chapel Hill, NC, USA), PM 2.5 (Personal Environment Monitors; CD NovaTech, Burnaby, BC, Canada) and NO 2 and NO X (Ogawa, Pompano Beach, FL, USA).
Women wore a small backpack with personal monitoring equipment for 48 h and also completed a time-activity diary for this period. The backpack was set up so that the air inlets and passive samplers were approximately in the breathing zone and participants were asked to wear the backpack at most times while mobile. If they were sitting or sleeping (i.e. in the home), the backpack could be placed on a surface at breathing level (not on the floor) in the room they were in.
During the personal sampling (48 h), we also placed an indoor air monitoring setup in the participants' home. This was located in the room primarily used by the participant (generally the living room) on a table about 1 m above the floor. Outdoor air monitoring was at a single location: the National Air Pollution Surveillance (NAPS) site maintained by Environment Canada. Air monitoring and equipment methods were consistent for indoor, outdoor and personal setups.
Airborne PAHs were collected with a sampler, which collected both particle-phase PAHs on a quartz micro-fiber filter and vapor-phase PAHs on a polyurethane foam (PUF) backup. Samplers were wrapped in black fabric or aluminum foil to minimize the effect of temperature on the sampler. The sampler was connected to an air sampling pump operating at 4 l/min. Immediately after sampling, the samplers were closed and stored in airtight bags in the fridge until being sent to the lab for analysis at the end of the week. Filters and PUF backups were extracted together, thus results contain both particle and vapor-phase PAHs. Airborne PM 2.5 (personal and indoor samples) was measured using an inline method with a personal PEM sampler with a 37 mm Teflon filter and a sampling pump operating at 1.8 l/min. Outdoor PM 2.5 was measured using TEOMs. Filters were measured gravimetrically following quality assurance guidelines (US EPA, 1998).
Nitrogen oxides were measured using Ogawa passive samplers (Ogawa). All Ogawa samplers were refrigerated during storage and shipping. Filters were extracted into de-ionized water and analyzed using ion chromatography. We collected five sets of field duplicates and used these to calculate a method precision of 4% for NO 2 and 8% for NO X .
We obtained additional air pollution exposure data (PM 2.5 , NO 2 and NO X ) from the two Hamilton sites of the NAPS network (site 1: downtown; site 2: on the escarpment) for the 24 h before each urine sample and each was assigned to participants by proximity. The 3rd trimester outdoor air samples were also located at the Hamilton NAPS downtown site (site 1 in Figure 1 ).
Quality Control
We collected 1 field blank per 10 air samples. If 450% of the field blanks were above the laboratory detection limits (LDL), then a field blank correction was applied to all samples (subtracting the median of the field blanks from the sample). After field blank correction, if applicable, any values that were below the LDL were replaced with 1/2 the LDL. No LDL was provided by the lab for the Ogawa samples, hence we calculated a method detection limit (DL) (three times the SD of the field blanks).
Calculation of PAHs in Food
For the 24 h before each urine sample, the women completed an open-ended food diary describing all food and beverages (type and portion sizes). Secondary questions included where the food was prepared (home or restaurant), whether the cooking type was ''fried, blackened or barbequed'' or if ''smoked meat, fish or nuts'' were consumed.
Each 24-h food diary was recoded manually to obtain portion sizes (by weight) from the USDA Food Search database (version 1.0, www.nal.usda.gov/fric/foodcomp) based on data from the Nutrient Data Laboratory. Along with investigating known sources of PAHs in food, such as barbequed meat, we also investigated other sources of PAHs in food, namely breads/cereals and oils/fats recently identified in a study in Barcelona (Martı´-cid et al., 2008) . Our food diary data were categorized to parallel the Barcelona study and we used their mean total PAHs mg/kg per food category (e.g. breads, vegetables, meats, fish) to estimate the total PAHs consumed in the 24 h. We also extracted from the 24-h food diary the frequency of eating any barbecued, broiled or grilled meats.
Geographic Data
Quantitative geographic variables were developed using ArcGIS/ArcMAP (Esri Canada). Because PAHs can be associated with both traffic and industrial activity, two groups of metrics were generated: one related to vehicle traffic (road metric) and a second related to industrial land-use. Each participant's home was geocoded by address (DMTI Streets 2006) . We calculated the distance to roads of two classifications: nearest highway and nearest highway or major road and the total number and area of land-use parcels classified as ''resource/industrial'' in 1000, 500 and 200 m radius buffers around each home.
Statistical Analysis
All analyses were conducted in SAS version 9.1 (SAS Institute, Cary, NC, USA).
We tested all PAH concentrations for normality and logtransformed (base e) to ensure normality. If greater than 80% of the values for a specific PAH were below the LDL after blank correction, then we excluded it from further analysis.
We assessed correlations for the air samples between-pollutant and between-sampling environments (personal-indoor-outdoor) using Pearson's correlations of log-transformed variables. Relevant determinants were assessed in univariate analysis using General Linear Models (PROC GLM) with both urinary OH-PAH metabolites and personal air PAHs as dependent variables. When appropriate, we developed mixed-effect models for the urine OH-PAHs based on questionnaire, food diary, air sampling data (personal, indoor and outdoor, and NAPS outdoor) and/or spatial data with subject included as a random effect. Variables were only considered in the multiple regression modeling if univariate results were robust (not driven by outliers) and significant (P-value o0.1). If two variables were highly similar or correlated, parallel models were developed. We verified all models with and without outliers (identified by Cooks' d statistic 40.1) and only models that were robust with and without outliers are presented, unless noted otherwise.
Results
In all, 19 participants completed all urine and indoor air samples. One woman did not complete her final personal air sample owing to medical reasons, but her other results were included. There were some differences in the characteristics of the study participants (Table 1) between the downtown and suburban groups. Specifically, the downtown groups were younger, more recent ex-smokers (quit at the start of pregnancy) and lived in older homes.
On average, the women spent 75% of their time indoors at home, 5% in transit, 6% indoors elsewhere and 11% indoors at work; most (14/19) had at least some post-secondary education. Although over half the study group were former smokers, very low environmental tobacco smoke (ETS) exposure was reported (two people reported 5-10 min/48 h). Results for food-related PAH intake are shown in Table 2 .
Air PAH Samples
Descriptive statistics for personal, indoor, outdoor (central site) and NAPS are presented in Table 3 . For the six lightest MW PAHs (naphthalene to anthracene) (Figure 2 ), our outdoor (central site) concentrations were generally lower than the indoor and personal concentrations. With increasing MW, this trend reverses. Our sampling methods were validated by comparing our outdoor 3rd trimester measurements (N ¼ 7) against the NAPS data at the downtown site (using ordinary least squares regression) for the corresponding 48 h, resulting in R 2 values of 0.94 for PM 2.5 and 0.82 for NO 2 . Correlations within PAH species for the lighter MW PAHs (Pearson's r ¼ 0.62-0.94, results not shown) and heavier MW PAHs (r ¼ 0.32-0.88) were high. Consequently, we calculated two composite PAH metrics: the sum of each of the groups (SLight-PAHs and SHeavy-PAHs). None of the measurements in the SLight-PAHs were below the DLs, whereas 43% of the values of heavy PAHs were.
Personal vs indoor SLight-PAHs and SHeavy-PAHs were well correlated (r ¼ 0.90 for SLight-PAHs, 0.89 for SHeavy-PAHs). Personal vs outdoor PAH measurements were correlated (r ¼ 0.78) for the SHeavy-PAHs only. We report associations for PAHs and other measured pollutants in the Supplementary Tables 1 and 2 .
Univariate analyses of the personal air PAH measurements (Table 4) showed a significant relationship for the SLight-PAHs with any incense use (N ¼ 3 participants) . Because the only participant who reported very frequent incense and candle use also had an extremely high personal air sample, we have shown results both with and without this outlier. Personal SLight-PAHs were also associated (model ANOVA P-value 40.1) with living downtown, indoor PAHs, and outdoor and personal PM 2.5 . Increased personal SHeavy-PAHs were associated with indoor SHeavy-PAHs and outdoor measured PAHs, outdoor NO X and PM 2.5 .
In multivariate regression modeling, we developed two valid models for the personal SLight-PAHs group: one including indoor SLight-PAHs and incense use (R 2 ¼ 0.76) and the other with time at home and incense use (R 2 ¼ 0.62) (not shown). No multivariate models were significant for the SHeavy-PAHs.
Urinary Metabolites of PAHs
Of the 20 creatinine-adjusted PAH metabolites (Table 2) , 10 metabolites had sufficient detectable values for analysis. Some of the urine biomarkers (2-FLUO and 3-PHEN) correlated moderately (r ¼ 0.58 and 0.45) with their parent PAH 3rd trimester air measurements (Supplementary Table 1 ). Group means of all metabolites were higher for the downtown population and differences were significant (Kruskal-Wallis Po0.05) for 9-FLUO, 3-PHEN and 1-PYR. There were no consistent trends in the urinary PAH metabolites across trimesters of pregnancy and no association with the month of sampling. No significant relationships were found between the outdoor NAPS-based pollutants (24 h before urine sample) and the urine metabolites. We observed moderate correlations between the urine biomarkers for all the FLUO metabolites, the PHEN metabolites and the 1-PYR metabolite (Pearson's r ¼ 0.4-0.88). The 1-NAP and 2-NAP were only slightly correlated with other metabolites (r ¼ 0.11-0.44) (Supplementary Figure 1) .
We observed a weak relationship with the calculated PAH intake in food and the 1-PYR urinary metabolites, which was not significant in mixed-effects or multivariate modeling. However, the frequency of eating smoked meats in the last month and having eaten any meat (barbeque, smoked, grilled or fried) in the previous 24 h (based on the food diary) was associated with urinary 1-PYR (P-value o0.05).
Results from the univariate analyses of the PAH biomarkers (Table 5) show that the 2-NAP biomarker was sensitive to smoking history (average cigarettes per day) and proximity to some outdoor sources (industry, restaurants). Most of the PHEN and FLUO metabolites were related to Bold indicates significant differences between groups, Po0.05.
PAHs in air and urine of pregnant women Nethery et al.
their parent PAHs in indoor and personal air samples. For the centrally monitored pollutants, only outdoor PM 2.5 was weakly associated with urinary 3-FLUO. The strongest mixed-effects multivariate models (including subject as a random effect to account for within-subject correlations in urine samples) are shown in Table 6 . A model for 2-NAP included a variable related to former smoking and any complications during pregnancy (y/n). The model for 3-FLUO included stove type (decreased urine concentration for having a gas stove), air PAH (fluorene) and a variable related to the size of the home (larger home ¼ decreased urine concentration). The model for 1-PYR was the only one to include food PAH exposure as well as indoor NO X . Interestingly, an increase in days of pregnancy also predicted an increase in 1-PYR concentration, suggesting either an increase in exposure with duration of pregnancy or a change in the bodies' ability to metabolize pyrene across pregnancy.
Discussion
Personal Exposures to PAHs in Air
The mean levels in this study are comparable to personal exposure studies in urban cities; however, many of those studies were in highly polluted areas. We report data for the individual PAH in the Supplementary Table 3. As studies often report different ''total PAH'' metrics, we will focus on pyrene and BaP for comparisons. The geometric mean (GM) personal concentrations in Hamilton were 0.94 ng/m 3 for pyrene and 0.10 ng/m 3 (only 28% of samples above the DL) for BaP. In comparison, personal air sampling among pregnant women in Poland (Choi et al., 2008b) reported GMs from 1.4 to 14.10 ng/m 3 for pyrene (depending on sampling season) and 0.46 to 10.66 ng/m 3 for BaP. Another study among pregnant minority women in New York City, NY, USA (Tonne et al., 2004) reported pyrene concentrations: (summer) mean ¼ 4.45 ng/m 3 and BaP mean ¼ 0.20 ng/m 3 . Levels closer to our study were found in three areas of the UK (N ¼ 100): pyrene GM ¼ 0.22 and BaP GM ¼ 0.09 (and all urban areas GM ¼ 0.11) (DelgadoSaborit et al., 2009; Aquilina et al., 2010) . Overall, the personal concentrations in Hamilton were lower than those in the two other cohorts of pregnant women in NYC and Krakow, Poland, but comparable or higher to those in the UK. Hamilton, Ontario is much smaller than either NYC or Krakow and has lower ambient air pollution, but is still more polluted than comparable Canadian urban centers without industrial areas in close proximity. Ambient weather Where the total number of samples is o57; this indicates that the remaining samples were invalid.
b Li et al. (2008) .
conditions affect air pollution of all types, including PAHs; hence, differences in sampling seasons make it difficult to compare between cities and studies. In our study, measurements in the September (summer) session were higher for some lighter PAHs and pyrene. The difference in ambient PAHs between sampling sessions was not an issue in the modeling for this study as we had indoor/outdoor concentration results for all sampling sessions and there were no significant differences in study participants' characteristics between the sessions. 
Determinants of Personal PAHs in Air
Personal-indoor PAH correlations were high for both groups of PAHs (with detectable results) and personal-outdoor correlations were high for SHeavy-PAHs only. In combination with the concentration ranges, this suggests that personal exposure to heavier MW PAHs is dominated by outdoor sources and lighter MW PAHs originated primarily from indoor sources. In epidemiological studies, it is common to predict personal exposures based on central site or outdoor monitoring. Our results, however, suggest that heavier MW PAHs could be measured at central sites as predictors of personal exposures, but PAHs with lower MW should not be estimated based on fixed monitoring sites. Relatively few studies have simultaneously monitored personal and indoor and outdoor PAHs. In Poland (Choi et al., 2008b) (where the only lighter PAH was pyrene), heavier MW PAHs' (benzo [a] anthracene to ideno[1,2,3-cd]pyrene) personal-indoor-outdoor correlations were very high (r ¼ 0.95-0.98) and slightly lower for pyrene (r ¼ 0.84-0.86).
For the SLight-PAHs, housing and lifestyle factors appear to have a stronger impact on personal exposure rather than outdoor levels. Indoor factors such as presence of candles or incense, time spent at home and number of rooms in the home (related to air exchange in the home) were found to be predictive and confirm previous findings (Tonne et al., 2004; Li et al., 2005) . Being a former smoker who quit before the start of pregnancy (n ¼ 5) was also associated with the SLight-PAHs. This is consistent with results reported elsewhere where ETS is an important contributor to personal exposure (Georgiadis et al., 2001) ; however, no significant current ETS was reported by our participants. One possibility is that past smoking in the home may have caused tobacco smoke chemicals to absorb onto housing materials (Singer et al., 2003) and be continuously released back into the air in the home. A second possibility is that the participants who recently quit smoking may occasionally smoke or have under-reported ETS exposure; however, we do not have any biomonitoring data to support this hypothesis. The density of industrial areas and living downtown were also predictors (higher levels in downtown and higher number of industries) in our study, which is consistent with the reported rural-urban PAH concentration difference in other locations (Li et al., 2005; Delgado-Saborit et al., 2009 ).
PAH Biomarkers: Levels of OH-PAHs in Urine
The GM OH-PAH urinary concentrations were similar or higher than those from the NHANES cohort (Li et al., 2008) (all adults 420 years; Table 2 ). This suggests that our study group in Hamilton has potentially higher PAH exposure than a reference sample of the US population. The highest concentrations (GM ¼ 2605 ng/g creatinine) were for 2-NAP, which is also consistent with NHANES; however, our measurements of 1-PYR, the heaviest MW metabolite with detectable measurements, were three times higher than the NHANES cohort.
Predictors of Urinary PAHs
Only a few valid multiple regression predictive models could be developed owing to the small sample size; however, both univariate and multivariate results indicate possible sources of individual body burdens of PAHs (based on urinary OH-PAHs) among pregnant women, which can inform future studies. It is important to note that multivariate modeling was extremely sensitive to outliers and models were limited because of collinearity (e.g. some NO 2 -NO X -PAH air samples were correlated).
For some fluorene and phenanthrene metabolites, we found weak relationships with the biomarkers and their parent air PAH compounds. Overall, the strongest correlations were Indoor NO X (ppb) X B X X Indoor PM 2.5 (mg/m with several lighter MW PAHs and 3-FLUO metabolites. This compares, in part, with a recent study in which participants gave repeated urine samples in tandem with personal air PAH monitoring. Those authors found that 1-NAP and 3-FLUO had the strongest relationship with their parent compounds in air (Li et al., 2010) in a nonsmoking group (n ¼ 8). We observed a similar relationship for 3-FLUO in our study, but not for 1-NAP, which was associated with a history of smoking and not with its parent PAH (air naphthalene). Others (Georgiadis et al., 2001 ) have demonstrated that increased exposure to ETS produced different PAH concentration profiles with, specifically, increased lighter air PAHs with higher ETS exposure, whereas in the UK, another study (Aquilina et al., 2010) found increased biomarkers for 2-PHEN and 3 þ 4-PHEN in a high ETS group, but not for 2-NAP (no 1-NAP results were reported). The results of our univariate analyses suggested impacts of outdoor sources (truck traffic, proximity to industry or restaurants) and smoking history on 2-NAP. The effect of candles and incense was seen for most OH-PAHs, but was highly driven by a single individual who was excluded from much of the analysis. The impact of smoking history (pack-years of smoking) on 1-NAP and 2-NAP is surprising considering the fact that the half-life of naphthalene in the body is very short (days). We speculate that either there is residual naphthalene remaining in the body after chronic exposure or there is some residual undetermined exposure (e.g. unreported ETS or residual tobacco emissions from housing materials).
Compared to a study conducted in Mariupol, Ukraine, with a strong industrial presence from steel mills and coke ovens (Mucha et al., 2006) , we found much lower air PAH (e.g. pyrene: Hamilton outdoor mean ¼ 1.3 ng/m 3 vs Mariupol, mean ¼ 7.6 ng/m 3 ) and 1-PYR concentrations (Hamilton: mean 0.082 mmol/mol creatinine; Mariupol (no ETS) mean 0.56 mmol/mol creatinine). However, while our levels were much lower, we still found an association with proximity to industry (both through living ''downtown'' and number of industrial areas) on personal urinary PAHs.
Even though we developed a detailed food metric including PAH intake from all sources in food, this was not significant in our analysis. 1-PYR was related to PAHs in food (based on barbequed/broiled meat consumption) rather than inhaled PAHs. We conclude, as did Li et al. (2010) , that 1-PYR is affected by food intake, whereas 2,3-FLUO is affected by air PAHs at lower levels of PAH air pollution (non-occupational populations).
The relationship with pre-pregnancy weight and length of pregnancy (days) (Tables 4 and 5) and urinary PAHs warrant further exploration in populations of pregnant women. It is possible that body mass should be considered externally to creatinine adjustment when looking at biomarkers. Days of PAHs in air and urine of pregnant women Nethery et al.
pregnancy in the 1-PYR model increased the urine concentration, suggesting that either exposure to this compound increased or was metabolized differently at various stages of the pregnancy. More detailed studies among pregnant women are needed to confirm and explain these observations.
Strengths and Limitations of the Study
This study is unique, to date, in having collected PAH biomarkers across all three trimesters of pregnancy in tandem with personal-indoor-outdoor air (PAHs and other pollutants) measurements. However, our sample size is small, we lack PAH air monitoring data from all trimesters, and our outdoor air PAH sampling was at a central monitoring station for the entire study group, hence we have no outdoor air PAH measurements specific to each residence. Because we also have extensive questionnaire data, it is possible that some results are due to random chance from multiple comparisons. However, we carefully examined all relationships with and without outliers.
Conclusions
In our pilot study in Hamilton, Canada, we found elevated air PAH and urinary PAH levels among pregnant women who lived in the downtown area. Comparing personal to indoor to outdoor air PAHs, the SLight-PAHs were more likely related to indoor sources, whereas the SHeavy-PAHs were related to outdoor sources. In our study, consistent predictors of urinary PAHs were smoking history (2-NAP), parent air PAHs (3-FLUO, 3-PHEN), consumption of broiled/barbecued foods (1-PYR) and proximity to industrial areas. If future studies wish to attempt to model ambient air exposure to PAHs in non-occupationally exposed groups using urinary PAH metabolites, then 1-PYR may not be appropriate as it appears to be strongly affected by ingested PAHs (food).
Other metabolites seem to have stronger relationships with air PAHs (while being unaffected by ingested PAHs), although 2-NAP was modified by smoking history. We also found some impact of spatial differences in exposure to outdoor ambient PAH sources in the urinary PAH metabolites (proximity to industrial areas), even though these were lighter MW PAHs and mostly driven by indoor sources. Urinary PAHs present an interesting method for assessing exposure to toxic air PAHs, which have been linked to adverse birth outcomes and other health effects. We identified some specific biomarkers of interest for further studies due to their relationships with air PAHs and/or being impacted by sources of concern (industrial proximity, incense or candle use).
